Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
30 studies found for:    " October 21, 2009":" November 20, 2009"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" October 21, 2009":" November 20, 2009"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Safety and Efficacy of Reduced Dose Efavirenz (EFV) With Standard Dose EFV Plus Two Nucleotide Reverse Transcriptase Inhibitors (N(t)RTI) in Antiretroviral-naïve HIV-infected Individuals.
Condition: HIV Infections
Intervention: Drug: Efavirenz
2 Completed Adherence-Suppression-Resistance Relationships for Atripla Compared to Historical Antiretroviral Regimens
Conditions: HIV Infections;   Adherence
Intervention:
3 Unknown  Computerized Counseling to Promote Positive Prevention and HIV Health in Kenya
Condition: HIV Infections
Interventions: Other: CARE+ Kenya brief computer risk assessment session;   Other: CARE+ Kenya computer counseling session
4 Completed A Spanish-Language Intervention to Enhance Routine HIV Patient Care Delivery [CARE+ Spanish]
Condition: HIV Infections
Interventions: Other: CARE+ Spanish computer counseling session;   Other: CARE+ Spanish brief computer risk assessment session
5 Completed Pilot Study of Text Message Reminders to Improve HIV Medication Adherence in Botswana
Condition: HIV Infections
Intervention: Other: Cell phone text message
6 Completed TMC278-TiDP6-C154: Evaluation of the Possible Influence of Omeprazole Intake - and the pH Increase in the Stomach Triggered by Omeprazole Intake - on the Blood Levels of TMC278 in Healthy Volunteers
Condition: HIV Infections
Intervention: Drug: TMC278; Omeprazole
7 Completed Clinical Trial to Evaluate the Immunogenicity and Safety of an Adjuvanted A(H1N1)v Influenza Vaccine and a Non-adjuvanted A(H1N1)v Influenza Vaccine in HIV-infected Patients (ANRS 151 Hifluvac)
Condition: HIV Infections
Interventions: Biological: adjuvanted A(H1N1)v influenza vaccine;   Biological: non-adjuvanted A(H1N1)v influenza vaccine
8 Terminated Pilot Study to Assess Gut Mucosal B Cells in Individuals With HCV and HIV
Conditions: HIV Infections;   Hepatitis C Virus
Intervention:
9 Completed Cardiovascular Risk Evaluation and Antiretrovirals in HIV
Conditions: Cardiovascular Risk;   HIV Infections
Intervention:
10 Completed Integrating Family Planning Services Into HIV Care and Treatment in Nyanza Province, Kenya
Conditions: Unintended Pregnancy;   HIV Infections
Intervention: Procedure: Integrated family planning/HIV care and treatment services
11 Completed
Has Results
Boosted Lexiva With Lovaza Adjunctive Therapy in Hypertriglyceridemic, HIV-Infected Subjects
Conditions: Hypertriglyceridemia;   HIV Infection
Interventions: Dietary Supplement: Lovaza;   Drug: fosamprenavir/ritonavir
12 Completed
Has Results
Safety and Immunogenicity of AERAS-402 in HIV-infected, Bacillus Calmette-Guerin (BCG)-Vaccinated Adults
Conditions: Tuberculosis;   HIV Infections
Interventions: Biological: AERAS-402;   Biological: Placebo
13 Unknown  Conjugate And Polysaccharide Vaccines Compared With Polysaccharide Vaccine In Hiv-Infected Adults
Conditions: Pneumococcal Vaccines;   HIV;   HIV Infections
Intervention: Biological: Prevenar and Pneumo23
14 Completed Reassessment of the Nutritional Status in Thai Orphans Living With HIV in a Family Style Community
Conditions: HIV Infection;   HIV Infections
Intervention:
15 Terminated Appropriate Timing of HAART in Co-infected HIV/TB Patients
Conditions: HIV Infections;   Tuberculosis
Intervention: Drug: tenofovir, lamivudine, efavirenz
16 Completed
Has Results
Pilot Placebo Controlled Study With Lovaza in Cardiovascular Disease
Conditions: HIV Infections;   Heart Disease
Interventions: Drug: Lovaza;   Drug: Placebo
17 Completed
Has Results
Immunization With HIV-1 Peptides in Adjuvant for Treatment of Patients With Chronic HIV-infection
Condition: HIV INFECTIONS
Intervention: Biological: peptide vaccine (AFO-18)
18 Completed Predictors of Antiretroviral Pharmacokinetics in HIV-infected Women With Virologic Suppression
Condition: Human Immunodeficiency Virus
Intervention:
19 Completed Ritonavir-boosted Lopinavir Monotherapy
Condition: HIV
Intervention: Drug: lopinavir/ritonavir soft gel capsule
20 Completed Motivational Enhancement System for Adherence
Condition: HIV
Interventions: Behavioral: Motivational Enhancement System for Adherence (MESA);   Behavioral: Motivational Enhancement System for Health (MESH)

   Previous Page Studies Shown (1-20) Next Page (21-30) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.